{"id":196,"date":"2017-09-07T15:36:40","date_gmt":"2017-09-07T15:36:40","guid":{"rendered":"http:\/\/www.pmsinstruments.co.uk\/blog\/?p=196"},"modified":"2018-01-19T14:32:01","modified_gmt":"2018-01-19T14:32:01","slug":"the-economic-case-for-the-alivecor-kardia-mobile-ecg","status":"publish","type":"post","link":"https:\/\/www.pmsinstruments.co.uk\/blog\/the-economic-case-for-the-alivecor-kardia-mobile-ecg\/","title":{"rendered":"The economic case for the AliveCor Kardia Mobile ECG"},"content":{"rendered":"<p>The AliveCor Kardia Mobile ECG has swiftly become one of our more popular products. If you\u2019ve not yet heard of it, the Kardia Mobile ECG is an incredibly handy and portable ECG monitor that is held in the patient\u2019s hand. The only thing it needs is a smart phone with the Kardia app installed.<\/p>\n<p>Using a single channel ECG monitor with automatic ECG evaluation, it can detect possible Atrial Fibrillation (AF). The smartphone application shows a real-time visualisation of the ECG recording, as well as historical data for comparisons.<\/p>\n<p>The device has been popular for the home market, for those needing to track either their own or a relative\u2019s health. However, there\u2019s a serious economic case for the Kardia Mobile ECG to become a standard for surgeries. If surgeries have access to the mobile ECG, to be able to supply to patients, a lot of time can be saved.<\/p>\n<p>Let\u2019s first look at the current representative pathway for patients presenting with palpitations according to a case study from NHS Coastal West Sussex.<\/p>\n<p><em>Patient present with palpitations &gt; Sees GP &gt; GP refers &gt; Hospital receives letter &gt; Consultant receives letter &gt; Outpatients &gt; 24hr ECG &gt; Negative Test &gt; Has 7-day ECG &gt; Outpatients and decision &gt; Has 7-day ECG &gt; Outpatient and decision &gt; Consider Implantable Loop Recorder (ILR) &gt; Put on waiting list &gt; Lost to system &gt; Sees GP &gt; GP writes letter &gt; Hospital receives letter.<\/em><\/p>\n<p>That\u2019s quite a list, 18 steps in all. Goodness knows the time, resource and cost this entire process could be to the system.<\/p>\n<p>Here\u2019s a potential pathway with the Kardia:<\/p>\n<p><em>Patient presents with palpitations &gt; Sees GP &gt; GP supplies Kardia Mobile ECG &gt; Symptomatic trace &gt; Sees GP &gt; Advice and management.<\/em><\/p>\n<p>Already, you can see where the Kardia Mobile ECG being part of your surgery\u2019s strategy could save valuable time and money. The aforementioned case study does give some idea for the potential savings to be made.<\/p>\n<p>The previously quoted pathway is costed up at \u00a31305, nearly \u00a36000 if the ILR (implantable loop recorder) is included. Whilst all of these steps and the costs suggested might not always be the case, it shows that it could be an expensive process. Taking into consideration that an estimated 2,000,000 people in the UK have Atrial Fibrillation, we simply must find a more sensible solution, the AliveCor Kardia Mobile ECG.<\/p>\n<p>The same pathway, with the inclusion of the Kardia Mobile ECG being supplied comes in at just \u00a3172.50. That\u2019s an incredible saving.<\/p>\n<p>Across the country, that\u2019s a potential saving of \u00a32,265,000,000 (without ILR, \u00a311,377,000,000 with ILR in every case) which is a staggering figure. This is no longer about whether surgeries \u00ad<em>should<\/em> be supplying the Kardia Mobile ECG, it\u2019s a case of when they start.<\/p>\n<p><strong>That time is now.<\/strong><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The AliveCor Kardia Mobile ECG has swiftly become one of our more popular products. If you\u2019ve not yet heard of it, the Kardia Mobile ECG is an incredibly handy and portable ECG monitor that is held in the patient\u2019s hand. The only thing it needs is a smart phone with the Kardia app installed. Using &hellip; <a href=\"https:\/\/www.pmsinstruments.co.uk\/blog\/the-economic-case-for-the-alivecor-kardia-mobile-ecg\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;The economic case for the AliveCor Kardia Mobile ECG&#8221;<\/span><\/a><\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[40,33,82,89],"tags":[35,84,42,4,28],"_links":{"self":[{"href":"https:\/\/www.pmsinstruments.co.uk\/blog\/wp-json\/wp\/v2\/posts\/196"}],"collection":[{"href":"https:\/\/www.pmsinstruments.co.uk\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pmsinstruments.co.uk\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pmsinstruments.co.uk\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pmsinstruments.co.uk\/blog\/wp-json\/wp\/v2\/comments?post=196"}],"version-history":[{"count":4,"href":"https:\/\/www.pmsinstruments.co.uk\/blog\/wp-json\/wp\/v2\/posts\/196\/revisions"}],"predecessor-version":[{"id":207,"href":"https:\/\/www.pmsinstruments.co.uk\/blog\/wp-json\/wp\/v2\/posts\/196\/revisions\/207"}],"wp:attachment":[{"href":"https:\/\/www.pmsinstruments.co.uk\/blog\/wp-json\/wp\/v2\/media?parent=196"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pmsinstruments.co.uk\/blog\/wp-json\/wp\/v2\/categories?post=196"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pmsinstruments.co.uk\/blog\/wp-json\/wp\/v2\/tags?post=196"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}